Successful treatment with fenofibrate of autoimmune hepatitis in a patient with rheumatoid arthritis [2]

Scandinavian Journal of Rheumatology

Volumn 36, Issue 3, 2007, Pages 235-236

  Okamoto, H ^a   Kamatani, N ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AURANOFIN; FENOFIBRATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

AGED; AUTOIMMUNE HEPATITIS; BLOOD CHEMISTRY; CASE REPORT; DRUG MECHANISM; ERYTHROCYTE COUNT; HUMAN; LETTER; MALE; METACARPOPHALANGEAL JOINT; POLYARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SWELLING; SYMPTOM; THERAPY EFFECT; WRIST;

AGED; ARTHRITIS, RHEUMATOID; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER; MALE; PROCETOFEN;

EID: 34547449780     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740600991828     Document Type: Letter

References (6)

1. Alverez F, Berg PA, Bianchi FB. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-38.
2. Johnson PJ, McFarlane IG, Williams R. Azathioprine for long-term maintenance of remission in autoimmunehepatitis. N Engl J Med 1995;333:958-63.
3. Staels B, Koenig W, Habib A, Merval R, Lebret M, Torra IP, et al. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature 1998;393:790-3.
4. Okamoto H, Kamatani N. Successful treatment with fenofibrate, a peroxisome proliferator activated receptor alpha ligand, for a patient with rheumatoid arthritis. Ann Rheum Dis 2004;63:1002-3.
5. Okamoto H, Iwamoto T, Kotake S, Momohara S, Yamanaka H, Kamatani N. Inhibition of NF-kappaB signaling by fenofibrate, a peroxisome proliferator-activated receptor-alpha ligand, presents a therapeutic strategy for rheumatoid arthritis. Clin Exp Rheumatol 2005;23:323-30.
6. Cornwell PD, De Souza AT, Ulrich RG. Profiling of hepatic gene expression in rats treated with fibric acid analogs. Mutat Res 2004;549:131-45.